{"pageContent": "Context: Evidence-based guidelines for active surveillance (AS), a treatment option for men with low-risk prostate cancer, recommend regular follow-up at periodic intervals to monitor disease progression. However, gaps in monitoring can lead to delayed detection of cancer progression, leading to a missed window of curability.", "metaData": {"source": "Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/16702374/"}}